SARCLISA 20 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION

Sanofi Winthrop Industrie🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 1ecae0748b48206e
Drug Cima Aemps Name: SARCLISA 20 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION
Register Number: 1201435001
Holder Company Name: Sanofi Winthrop Industrie
Marketing Company Name: Sanofi Aventis S.A.
Holder Company Detail Path: /organization/sanofi-winthrop-industrie
Authorization Date: 2020-07-05
Dosage Form: CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Dose: 20 mg/ml
Route Of Administration: VÍA INTRAVENOSA
Prescription Type: Uso Hospitalario
Commercialized: Yes
Company Name: Sanofi Winthrop Industrie
Company Detail Path: /organization/sanofi-winthrop-industrie

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Jul 5, 2020

Approval ID

1ecae0748b48206e

Type

Standard